Search company, investor...

Compare Merrimack Pharmaceuticals vs Protalex

Customers evaluate the quality of Merrimack Pharmaceuticals's products using the following success metrics.

Overview

Merrimack Pharmaceuticals is 31 yrs old and is based in United States.

Merrimack Pharmaceuticals (NASDAQ: MACK) is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the treatment of serious diseases, with a focus on cancer. The company's mission is to provide patients, physicians, and the healthcare system with the medicines, tools, and information to transform the approach to care from one based on the identification and treatment of symptoms to one focused on the diagnosis and treatment of illness through a more precise mechanistic understanding of disease.

Protalex Logo

Protalex is 25 yrs old and is based in United States.

Protalex (www.protalex.com) is a biotechnology company engaged in the development of a new class of immunomodulatory drugs for treatment of rheumatoid arthritis and other autoimmune diseases. The company takes a unique approach towards autoimmune diseases as its drugs act upon cells at the primitive level of function. The company will enter Phase I clinical trials within the next year for its first drug that addresses Rheumatoid Arthritis. Pre-clinical studies in Lupus and Chron's disease are set to begin in the fourth quarter of 2004.

Country

United States

Demo Video

Demo not available because Merrimack Pharmaceuticals has not claimed their profile.

Work for Merrimack Pharmaceuticals? Show off your product.

Demo not available because Protalex has not claimed their profile.

Work for Protalex? Show off your product.

Leadership

Robert J Mulroy (Chief Executive Officer, President)

See all 5 people

Funding

Merrimack Pharmaceuticals last raised $100.1M on 3/29/2012.
Protalex last raised $15.18M on 7/12/2006.

Total Raised

$17.72M

Investors

Sorenson Development, GTC Biotherapeutics

See all 5 investors

vSpring Capital, Nite Capital Management

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Merrimack Pharmaceuticals has not claimed their profile.

Work for Merrimack Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Merrimack Pharmaceuticals?

Claim your profile now.

Information not available because Protalex has not claimed their profile.

Work for Protalex? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Protalex?

Claim your profile now.